Randall Michael Giuffre - Jun 23, 2023 Form 4 Insider Report for DiaMedica Therapeutics Inc. (DMAC)

Role
Director
Signature
/s/ Amy E. Culbert, attorney-in-fact
Stock symbol
DMAC
Transactions as of
Jun 23, 2023
Transactions value $
$254,150
Form type
4
Date filed
6/26/2023, 04:42 PM
Previous filing
Jun 2, 2023
Next filing
Jan 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DMAC Voting Common Shares, no par value per share Purchase $254K +65K +22.01% $3.91 360K Jun 23, 2023 Direct F1
transaction DMAC Voting Common Shares, no par value per share Gift $0 -15K -4.16% $0.00 345K Jun 23, 2023 Direct
holding DMAC Voting Common Shares, no par value per share 25.6K Jun 23, 2023 See footnote F2
holding DMAC Voting Common Shares, no par value per share 21.1K Jun 23, 2023 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 64,959 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, 164,890 voting common shares held by Michael Giuffre and his wife jointly and 61,360 voting common shares held by Michael Giuffre individually.
F2 These voting common shares are held by 424822 Albert Ltd, of which Michael Giuffre has sole voting and dispositive power.